Kigali, Nov 26 (IANS) Rwanda and the International Vaccine Institute (IVI) signed an agreement Monday to establish the institute’s African Regional Office in Kigali, the Rwandan capital.
The agreement, signed by Rwanda’s Minister of Health Sabin Nsanzimana and IVI Director General Jerome Kim, paves the way for the regional headquarters to serve as a hub for global health research, innovation, and collaboration, the Ministry of Health said in a statement.
“The establishment of the International Vaccine Institute in Rwanda marks a significant step toward the sustained advancement of healthcare research and equitable access to vaccines across the continent and beyond,” said Nsanzimana, adding that Rwanda is committed to addressing vaccine inequities through local production of vaccines, therapeutics, and other life-saving medical products.
The Kigali-based IVI office said it will represent IVI in Africa, expand its member base and engagement, and emphasize clinical trial training capacity. It will also foster joint grant applications with local partners to accelerate vaccine research and innovation across the continent, Xinhua news agency reported.
The IVI, headquartered in Seoul, the Republic of Korea, was established in 1997 under the initiative of the United Nations Development Program. Its mission is to discover, develop, and deliver safe, effective, and affordable vaccines for global health. Rwanda was chosen to host the African office following a rigorous evaluation of proposals from five African nations.
Early this month, Rwanda and the African Union (AU) inaugurated the African Medicines Agency headquarters in Kigali, paving the way for the continental regulatory body’s operations. The specialized AU agency will facilitate pandemic preparedness, expand access to medicines, support collaboration among regulators, and build resilient health systems across the continent.
Rwanda is also the first of three African nations to host an mRNA manufacturing facility, with vaccines dedicated to serving AU members and advancing access to innovative medicines.
–IANS
as/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
